Ascendis Pharma A/S Interest Expense
Ascendis Pharma A/S (ASND) reported Interest Expense of EUR 80.65 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-02-11
| Period end | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | 80.65M EUR 20-F · filed 2026-02-11 | |
| 2024-12-31 | 65.50M EUR 20-F · filed 2026-02-11 | |
| 2023-12-31 | 44.06M EUR 20-F · filed 2026-02-11 | |
| 2022-12-31 | 30.68M EUR 20-F · filed 2025-02-12 | |
| 2021-12-31 | 3.91M EUR 20-F · filed 2024-02-07 | |
| 2020-12-31 | 1.92M EUR 20-F · filed 2023-02-16 | |
| 2019-12-31 | 1.22M EUR 20-F · filed 2022-03-02 | 207.00K EUR 20-F · filed 2020-04-03 |
| 2018-12-31 | 127.00K EUR 20-F · filed 2021-03-10 | |
| 2017-12-31 | 97.00K EUR 20-F · filed 2020-04-03 | |
| 2016-12-31 | 5.00K EUR 20-F · filed 2019-04-03 | |
| 2015-12-31 | 6.00K EUR 20-F · filed 2018-03-28 |